The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Independent Human MAP-Kinase Signal Transduction Pathways Defined by MEK and MKK Isoforms
Abstract
Mammalian mitogen-activated protein (MAP) kinases include extracellular signal-regulated protein kinase (ERK), c-Jun amino-terminal kinase (JNK), and p38 subgroups. These MAP kinase isoforms are activated by dual phosphorylation on threonine and tyrosine. Two human MAP kinase kinases (MKK3 and MKK4) were cloned that phosphorylate and activate p38 MAP kinase. These MKK isoforms did not activate the ERK subgroup of MAP kinases, but MKK4 did activate JNK. These data demonstrate that the activators of p38 (MKK3 and MKK4), JNK (MKK4), and ERK (MEK1 and MEK2) define independent MAP kinase signal transduction pathways.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a peptide derived from MKK4 (pepMKK4) bound to JNK1 and p38α with similar affinities, as expected.”
From Specificity of Linear Motifs That Bind to a Common Mitogen-Activated Protein Kinase Docking Groove (2012) · cites this paper as [23]
Citations
Cites
Site-directed mutagenesis by overlap extension using the polymerase chain reaction
Ho, S. N., Hunt, H. D., Horton, R. M., Pullen, J. K., & Pease, L. R. (1989) · Gene · doi:10.1016/0378-1119(89)90358-2 · Cited by 7,414
Smith, D. B., & Johnson, K. S. (1988) · Gene · doi:10.1016/0378-1119(88)90005-4 · Cited by 5,844
Dérijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., Deng, T., Karin, M., & Davis, R. J. (1994) · Cell · doi:10.1016/0092-8674(94)90380-8 · Cited by 3,188
Self-citationA MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian Cells
Han, J., Lee, J. D., Bibbs, L., & Ulevitch, R. J. (1994) · Science · doi:10.1126/science.7914033 · Cited by 2,647
Self-citationThe stress-activated protein kinase subfamily of c-Jun kinases
Kyriakis, J. M., Banerjee, P. T., Nikolakaki, E., Dai, T., Rubie, E. A., Ahmad, M. F., Avruch, J., & Woodgett, J. R. (1994) · Nature · doi:10.1038/369156a0 · Cited by 2,601
The mitogen-activated protein kinase signal transduction pathway
Davis, R. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82362-6 · Cited by 2,112
Self-citationRouse, J. W., Cohen, P., Trigon, S., Morange, M., Alonso‐Llamazares, A., Zamanillo, D., Hunt, T., & Nebreda, Á. R. (1994) · Cell · doi:10.1016/0092-8674(94)90277-1 · Cited by 1,671
Transcription Factor ATF2 Regulation by the JNK Signal Transduction Pathway
Gupta, S., Campbell, D., Dérijard, B., & Davis, R. J. (1995) · Science · doi:10.1126/science.7824938 · Cited by 1,433
Self-citationAn Osmosensing Signal Transduction Pathway in Yeast
Brewster, J. L., de Valoir, T., Dwyer, N. D., Winter, E., & Gustin, M. C. (1993) · Science · doi:10.1126/science.7681220 · Cited by 1,248
Andersson, S., Davis, D. L., Dahlbäck, H., Jörnvall, H., & Russell, D. W. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83172-6 · Cited by 1,229
Flagged first, then by citations
Research works printed but not linked: 1
- DRESSLER, H, BIOTECHNIQUES 13: 866 (1992).
Cited by
Sorted by citations
Items 901–999 of 999
McCubrey, J. A., Abrams, S. L., Stadelman, K. M., Chappell, W. H., LaHair, M. M., Ferland, R. A., & Steelman, L. S. (2009) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2009.10.016 · Cited by 44
“Activated ERK1 and ERK2 serine S/T kinases phosphorylate and activate a variety of substrates, including p90Rsk1 (Derijard et al., 1995; Xing et al., 1996; Cardon et al., 1998; Allan et al., 2003; McCubrey et al., 2007;).”
BackgroundXu (2010) · International Journal of Oncology · doi:10.3892/ijo.2010.855 · Cited by 44
Involvement of the Mitogen-activated Protein Kinase Family in Tetracaine-induced PC12 Cell Death
Tan, Z., Dohi, S., Chen, J., Banno, Y., & Nozawa, Y. (2002) · Anesthesiology · doi:10.1097/00000542-200205000-00024 · Cited by 44
Are MAP Kinases Drug Targets? Yes, but Difficult Ones
Margutti, S., & Laufer, S. (2007) · ChemMedChem · doi:10.1002/cmdc.200600271 · Cited by 45
Naumann, M., Rudel, T., Wieland, B., Bartsch, C., & Meyer, T. F. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.7.1277 · Cited by 44
Folgueira, M. D., Algeciras, A., MacMorran, W. S., Bren, G. D., & Paya, C. V. (1996) · Journal of Virology · doi:10.1128/jvi.70.4.2332-2338.1996 · Cited by 44
“Future studies will need to assess whether MEK or its downstream kinase (ERK) participates in targeting IkBa or, alternatively, whether more recently identified pathways such as those targeting JNK or p38 (15) are involved.”
BackgroundTargeting apoptosis in cancer chemotherapy
Makin, G. (2002) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.6.1.73 · Cited by 43
“Although these pathways share many similarities they are clearly independent [31]:”
BackgroundRole of NF-κB/RelA and MAPK Pathways in Keratinocytes in Response to Sulfur Mustard
Rebholz, B., Kehe, K., Ruzicka, T., & Rupec, R. A. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701234 · Cited by 44
Tang, B., Du, J., Wang, J., Tan, G., Gao, Z., Wang, Z., & Wang, L. (2011) · Oncology Reports · doi:10.3892/or.2011.1580 · Cited by 43
RetractedO'Neill, L. A. J. (2000) · Science s STKE · doi:10.1126/stke.442000re1 · Cited by 99
Kawasaki, H., Moriguchi, T., Matsuda, S., Li, H. Z., Nakamura, S., Shtmohama, S., Kimura, J., Gotoh, Y., & Nishida, E. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.00315.x · Cited by 43
Cohen, P. (1996) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60574-8 · Cited by 43
Reconstitution of novel signalling cascades responding to cellular stresses
Woodgett, J. R., Kyriakis, J. M., Avruch, J., Zon, L. I., Zanke, B. W., Templeton, D. J., & Marshall, C. J. (1996) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1996.0009 · Cited by 43
Adegbola, P. I., & Adetutu, A. (2024) · Toxicology Reports · doi:10.1016/j.toxrep.2024.04.010 · Cited by 45
Endothelial MKK3 Is a Critical Mediator of Lethal Murine Endotoxemia and Acute Lung Injury
Mannam, P., Zhang, X., Shan, P., Zhang, Y., Shinn, A. S., Zhang, Y., & Lee, P. J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1202012 · Cited by 42
“activates p38, but not JNK or ERK, in response to stress (5).”
BackgroundSałaciak, K., & Pytka, K. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107872 · Cited by 42
Ai-hong, M. (2002) · World Journal of Gastroenterology · doi:10.3748/wjg.v8.i4.712 · Cited by 42
“In contrast, our data do not support the idea that CCK-8 may be mediating the antiinflammatory effects by the production of NO, to which antiinflammatory effects also have been described[ 29 ].”
ResultBurk, D. R., Senechal-Willis, P., Lopez, L. C., Hogue, B. G., & Daskalova, S. M. (2009) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.09.026 · Cited by 42
p62 Functions as a p38 MAP Kinase Regulator
SUDO, T., Maruyama, M., & Osada, H. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2333 · Cited by 42
Lee, J.-K., Hwang, W.-S., Lee, Y.-D., & Han, P. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00035-2 · Cited by 42
Gringhuis, S. I., de Leij, L. F. M. H., Wayman, G. A., Tokumitsu, H., & Vellenga, E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31809 · Cited by 42
Chemoproteomic profiling of kinases in live cells using electrophilic sulfonyl triazole probes
Huang, T., Hosseinibarkooie, S., Borne, A. L., Granade, M. E., Brulet, J. W., Harris, T. E., Ferris, H. A., & Hsu, K. (2021) · Chemical Science · doi:10.1039/d0sc06623k · Cited by 42
A Chemical Proteomic Map of Heme–Protein Interactions
Homan, R. A., Jadhav, A. M., Conway, L. P., & Parker, C. G. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c06104 · Cited by 43
Loss of Cellular K+ Mimics Ribotoxic Stress
Iordanov, M. S., & Magun, B. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3528 · Cited by 41
Lu, M. L., Sato, M., Cao, B., & Richie, J. P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.8977 · Cited by 41
Selective activation of JNK/SAPK by interleukin‐1 in rabbit liver is mediated by MKK7
Finch, A. J., Holland, P. M., Cooper, J. A., Saklatvala, J., & Kracht, M. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01364-1 · Cited by 41
Carel, K. D., Kummer, J. L., Schubert, C., Leitner, W., Heidenreich, K. A., & Draznin, B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.48.30625 · Cited by 41
p38 MAPK regulates steroidogenesis through transcriptional repression of STAR gene
Zaidi, S. K., Shen, W., Bittner, S., Bittner, A., McLean, M. P., Han, J., Davis, R. J., Kraemer, F. B., & Azhar, S. (2014) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0287 · Cited by 42
“To more directly define the roles that MKK3 and MKK6 play in p38 negative regulation of the Star promoter activity mediated by MAPKs, we assessed the expression of Star promoter activity in MEFs with targeted disruption of Mkk3 (Map2k3), Mkk6 (Map2k6) or both Mkk3 and Mkk6 genes.”
InfluentialSelf-citationp38 MAP Kinase Inhibits Neutrophil Development Through Phosphorylation of C/EBPα on Serine 21
Geest, C. R., Buitenhuis, M., Laarhoven, A. G., Bierings, M., Bruin, M. C. A., Vellenga, E., & Coffer, P. J. (2009) · Stem Cells · doi:10.1002/stem.152 · Cited by 40
Qian, F., Deng, J., Wang, G., Ye, R. D., & Christman, J. W. (2016) · Current Protein and Peptide Science · doi:10.2174/1389203716666150629121324 · Cited by 40
“In response to stress, the signal axis of MKK3/p38 MAPK/MK2 is strictly regulated, in which MKK3 specifically phosphorylates p38 MAPK, but not JNK or ERK, while p38 MAPK preferentially phosphorylates MK2 [86].”
BackgroundWeizman, N., Shiloh, Y., & Barzilai, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211168200 · Cited by 40
Aluoch, A. O., Odman‐Ghazi, S. O., & Whalen, M. M. (2006) · Toxicology · doi:10.1016/j.tox.2006.05.002 · Cited by 40
Yoshii, S., Tanaka, M., Otsuki, Y., Fujiyama, T., Kataoka, H., Arai, H., Hanai, H., & Sugimura, H. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.20.6796-6807.2001 · Cited by 40
“In addition, coexpression of kinase-negative SEK1 (K220A, K224L), which is one of the MAPK kinases and lies upstream of JNK1 (14), also strongly suppressed B(a)P-induced JNK1 activation (lane 10).”
BackgroundChin, A. I., Shu, J., Shi, C. S., Yao, Z., Kehrl, J. H., & Cheng, G. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.6665 · Cited by 40
“Supporting this prediction, the dimerization of full-length TANK is weaker by coimmunoprecipitation than dimerization of TANK-N with itself, although TANK-N expression is severalfold lower, suggesting that the potential intramolecular interaction between TANK-N and TANK-C may be inhibitory to TANK dimerization through…”
BackgroundMethodInfluentialPI3K signaling in the murine kidney inner medullary cell response to urea
Zhang, Z., Yang, X.-Y., Soltoff, S. P., & Cohen, D. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.278.1.f155 · Cited by 40
Kuroki, D. W., Minden, A., Sánchez, I., & Wattenberg, E. V. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.38.23905 · Cited by 40
A Novel Mechanism of G Protein-dependent Phosphorylation of Vasodilator-stimulated Phosphoprotein
Profirovic, J., Gorovoy, M. S., Niu, J., Pavlovic, S., & Voyno-Yasenetskaya, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501361200 · Cited by 40
Yamauchi, J., Tsujimoto, G., Kaziro, Y., & Itoh, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011752200 · Cited by 40
Thyroid Cancer: Current Molecular Perspectives
Giusti, F., Falchetti, A., Franceschelli, F., Marini, F., Tanini, A., & Brandi, M. L. (2010) · Journal of Oncology · doi:10.1155/2010/351679 · Cited by 39
“Activated ERKs are pleiotropic effectors of cell physiology and play an important role in the control of gene expression involved in the cell division cycle, apoptosis, cell differentiation, and cell migration [40, 41].”
Citrinin induces apoptosis in mouse embryonic stem cells
Chan, W. (2008) · IUBMB Life · doi:10.1002/iub.30 · Cited by 39
Alternative Splicing of MAPKs in the Regulation of Signaling Specificity
Maik-Rachline, G., Wortzel, I., & Seger, R. (2021) · Cells · doi:10.3390/cells10123466 · Cited by 41
“In particular, while MKK7 is specific to JNKs, MKK4 can also phosphorylate p38 and induce its full activation [67].”
BackgroundHashimoto, H., Fukuda, M., Matsuo, Y., Yokoyama, Y., Nishida, E., Toyohara, H., & Sakaguchi, M. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01479.x · Cited by 39
“There is the potential for crosstalk between these pathways because of MKK4 (SEK1) which has been shown to activate both p38 and JNK [15].”
BackgroundYing, J. I. N., Fan, Y., Yan, E., Liu, Z., Zong, Z., & Zhi-min, Q. I. (2006) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2006.00414.x · Cited by 39
Langereis, J. D., Raaijmakers, H. A. J. A., Ulfman, L. H., & Koenderman, L. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0809544 · Cited by 39
“E-mail: l.koenderman@umcutrecht Abbreviations: 7-AAD 7-amino-actinomycin, CAPE caffeic acid phenethyl ester, CHX cyclohexamide, COPD chronic obstructive pulmonary disease, IL-1Ra IL-1 receptor antagonist, MAPKAPK2 MAPK-AP kinase 2, MKK MEK kinase, MKK3/6 MKK3 and MKK6, NEMO NF- B essential modulator, PAF platelet-acti…”
BackgroundInfluentialPanopoulos, A., Harraz, M. M., Engelhardt, J. F., & Zandi, E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409524200 · Cited by 39
Kim, W.-J., Rajasekaran, B., & Brown, K. D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701451200 · Cited by 40
Vallejo, J. G., Knuefermann, P., Mann, D. L., & Sivasubramanian, N. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.1.419 · Cited by 39
“In general, the ERKs are largely involved in pathways leading to cell proliferation as a consequence of growth factor stimulation, whereas JNK and p38 MAPK are activated in response to a variety of cytokines and stress conditions (29).”
BackgroundHochholdinger, F., Baier, G., Nogalo, A., Bauer, B., Grunicke, H. H., & Überall, F. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.12.8052 · Cited by 39
Inhibition of apoptotic signaling pathways in cancer cells as a mechanism of chemotherapy resistance
Haq, R., & Zanke, B. W. (1998) · Cancer and Metastasis Reviews · doi:10.1023/a:1006075007857 · Cited by 39
Lee, S. A., Dritschilo, A., & Jung, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32889 · Cited by 39
Milne, M. L., Kang, M.-I., Cardona, G. R., Quail, J. M., Braverman, L. E., Chin, W. W., & Baran, D. T. (1999) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19990915)74:4 · Cited by 29
Rho GTPases as therapeutic targets for the treatment of inflammatory diseases
Zhao, D., & Pothoulakis, C. (2003) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.7.5.583 · Cited by 38
“The signal pathway by which Rac1 and Cdc42 activate JNK is mediated by the MAPK kinase kinase (MEKK) [74,77], which phosphorylates the MAPK kinase JNK kinase (JNKK or SEK1 or MKK4) and MKK3/6 for p38 activation [78-80].”
BackgroundPotin, S., Bertoglio, J. H., & Bréard, J. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.12.016 · Cited by 39
Kagan, B. L., Henke, R. T., Cabal-Manzano, R. H., Stoica, G. E., Nguyen, Q. T., Wellstein, A., & Riegel, A. T. (2003) · PubMed · Cited by 38
Murine Lyme Arthritis Development Mediated by p38 Mitogen-Activated Protein Kinase Activity
Anguíta, J., Barthold, S. W., Persinski, R., Hedrick, M. N., Huy, C. A., Davis, R. J., Flavell, R. A., & Fikrig, E. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6352 · Cited by 38
“In vitro studies demonstrate that activating transcription factor 2 is phosphorylated and activated by p38 MAP kinase (44, 46, 49).”
BackgroundSelf-citationNew, L., Li, Y., Ge, B., Zhong, H., Mansbridge, J. N., Liu, K., & Han, J. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.1253 · Cited by 37
“Since MEK1/2 has been indicated as potential activators of ERK1/2 in vivo [Derijard et al., 1995; Butch and Guan, 1996], we also investigated MEK1/2 activation in the experiment.”
BackgroundSelf-citationActivation of Mitogen-activated Protein Kinase Kinase (MKK) 3 and MKK6 by Type I Interferons
Li, Y., Batra, S., Sassano, A., Majchrzak, B., Levy, D. E., Gaestel, M., Fish, E. N., Davis, R. J., & Platanias, L. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410972200 · Cited by 37
Self-citationShimada, N., Rios, I., Moran, H., Sayers, B., & Hubbard, K. (2009) · RNA Biology · doi:10.4161/rna.6.3.8497 · Cited by 37
Molecular and Cellular Biology of Neuroprotection in the CNS
Alzheimer, C., Neuroprotection, O., Alzheimer, C., & Alzheimer, E. C. (2002) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0123-7 · Cited by 38
Guo, L., Urban, J. F., Zhu, J., & Paul, W. E. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.3984 · Cited by 37
“AP-1 is regulated by phosphorylation as well as by induction (43); p38 has been reported to mediate such phosphorylation (44).”
BackgroundBechoua, S., & Daniel, L. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101265200 · Cited by 37
Schröder, N. W. J., Pfeil, D., Opitz, B., Michelsen, K. S., Amberger, J. C., Zähringer, U., Göbel, U. B., & Schumann, R. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008954200 · Cited by 37
Hernández, M., Bayón, Y., Crespo, M. S., & Nieto, M. L. (1997) · Biochemical Journal · doi:10.1042/bj3280263 · Cited by 37
Lymphocyte activation the coming of the protein tyrosine phosphatases
Mustelin, T. (1998) · Frontiers in bioscience · doi:10.2741/a346 · Cited by 37
Huth, H. W., Albarnaz, J. D., Torres, A. A., Bonjardim, C. A., & Ropert, C. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.05.009 · Cited by 36
Methotrexate-induced apoptosis in hepatocytes after partial hepatectomy
Kobayashi, K., Terada, C., & Tsukamoto, I. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01264-5 · Cited by 36
Loss of Wip1 Sensitizes Cells to Stress- and DNA Damage-induced Apoptosis
Xia, Y. F., Ongusaha, P. P., Lee, S. W., & Liou, Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.007823 · Cited by 37
Sensitivity and Specificity Amplification in Signal Transduction
Li, G., & Qian, H. (2003) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:39:1:45 · Cited by 36
“Although MAPKK exhibits highest affinity for its physiological substrate, it can phosphorylate multiple MAPKs and possibly other proteins in the cell, despite with lower efficiency (56,57).”
Igarashi, Yamaguchi, Hirata, Daimon, Tominaga, & Kato (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00671.x · Cited by 36
Shim, J., Park, H.-S., Kim, M., Park, J., Park, E., Cho, S., Eom, S. J., Lee, H.-W., Joe, C. O., & Choi, E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.19.14107 · Cited by 36
Zhang, W., Chen, T., Wan, T. Y., He, L., Li, N., Yuan, Z., & Cao, X. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3244 · Cited by 36
López-Fontanals, M., Rodriguez-Mulero, S., Casado, F. J., Dérijard, B., & Pastor‐Anglada, M. (2003) · The Journal of General Physiology · doi:10.1085/jgp.200308800 · Cited by 36
“The former overexpresses the human wild-type JNK1 protein, whereas the latter corresponds to a mutated JNK1 form, in which the phosphorylation site TPY has been replaced by the APF sequence, as described elsewhere (Dérijard et al., 1995). pCDNA3 alone was used as a transfection control.”
BackgroundMethodInfluentialSelf-citationKarahashi, H., Nagata, K., Ishii, K., & Amano, F. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00045-4 · Cited by 36
Standaert, M. L., Bandyopadhyay, G. K., Antwi, E. K., & Farese, R. V. (1999) · Endocrinology · doi:10.1210/endo.140.5.6699 · Cited by 36
Prolactin Stimulates Activation of c-jun N-Terminal Kinase (JNK)
Schwertfeger, K. L., Hunter, S., Heasley, L. E., Levresse, V., Leon, R. P., DeGregori, J. V., & Anderson, S. M. (2000) · Molecular Endocrinology · doi:10.1210/me.14.10.1592 · Cited by 36
Lew, A. M., Glogauer, M., & Mculloch, C. A. (1999) · PubMed Central · Cited by 36
p38 mitogen-activated protein kinase plays a key role in regulating MAPKAPK2 expression
SUDO, T., Kawai, K., Matsuzaki, H., & Osada, H. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.063 · Cited by 35
Glucose‐dependent regulation of osteoclast H+‐ATPase expression: Potential role of p38 MAP‐kinase
Larsen, K. I., Falany, M. L., Ponomareva, L. V., Wang, W., & Williams, J. P. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10252 · Cited by 35
“and tyrosine residues by upstream activators, MKK3 or MKK6 [Derijard et al., 1995].”
BackgroundInfluentialLee, S. J., Kang, J. G., Ryu, O. H., Kim, C. S., Ihm, S., Choi, M. G., Yoo, H. J., Kim, D. S., & Kim, T. W. (2009) · Metabolism · doi:10.1016/j.metabol.2008.12.006 · Cited by 35
Gao, F., Li, F., Miao, Y., Xu, L.-J., Zhao, Y., Li, Q., Zhang, S.-H., Wu, J., Sun, X.-H., & Wang, Z. (2017) · Scientific Reports · doi:10.1038/s41598-017-01557-y · Cited by 34
Gibbs, B. F., Plath, K. E. S., Wolff, H. H., & Grabbe, J. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.2.391 · Cited by 34
“Additionally, we observed that these inhibitors blocked MKK3/MKK6 phosphorylation, which is known to directly activate p38 MAPK [39–41] using antibodies directed against phospho Ser189 and Ser207 residues on MKK3 and MKK6, respectively (Fig.”
BackgroundClanachan, A. S., Jaswal, J. S., Gandhi, M., Bottorff, D. A., Coughlin, J. J., Finegan, B. A., & Stone, J. C. (2003) · Transplantation · doi:10.1097/01.tp.0000040429.40245.3a · Cited by 34
“The basis for this complexity may stem from the existence of multiple and often shared upstream regulatory kinases (9).”
BackgroundMEKK3-mediated signaling to p38 kinase and TonE in hypertonically stressed kidney cells
Padda, R. S., Wamsley-Davis, A., Gustin, M. C., Ross, R., Yu, C. K. H., & Sheikh‐Hamad, D. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00377.2005 · Cited by 34
Oxygen sensing and response to hypoxia by mammalian cells
Wang, G.-L., & Semenza, G. L. (1996) · Redox Report · doi:10.1080/13510002.1996.11747034 · Cited by 35
Okumura, K., Shirasawa, S., Nishioka, M., & Sasazuki, T. (1999) · PubMed · Cited by 34
Butterfield, L., Zentrich, E., Beekman, A. M., & Heasley, L. E. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3380681 · Cited by 33
Nunès, J. A., Battifora, M., Woodgett, J. R., Truneh, A., Olive, D., & Cantrell, D. A. (1996) · Molecular Immunology · doi:10.1016/0161-5890(95)00121-2 · Cited by 34
Jabado, N., Pallier, A., Jauliac, S., Fischer, A., & Hivroz, C. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270209 · Cited by 34
Huang, L., Shi, L., Li, M., Yin, X., & Ji, X. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5513 · Cited by 43
Signalling mechanisms involved in renal pathological changes during cisplatin-induced nephropathy
Jaiman, S., Sharma, A. K., Singh, K., & Khanna, D. (2013) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-013-1568-7 · Cited by 33
“was the first member of the MAPK family to be identified and cloned from a vertebrate species in the early 1980’s [58–61].”
BackgroundTamamori‐Adachi, M., Koga, A., Susa, T., Fujii, H., Tsuchiya, M., Okinaga, H., Hisaki, H., Iizuka, M., Kitajima, S., & Okazaki, T. (2018) · Scientific Reports · doi:10.1038/s41598-018-27938-5 · Cited by 33
Suhail, T. V., Singh, P., & Manna, T. K. (2015) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2014.12.001 · Cited by 33
Wang, J., Tseng, J. T.-C., & Chang, W. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-02-0105 · Cited by 33
“p38MAPK can be phosphorylated and activated by the dual-specific protein kinases MKK3 and MKK6 (Derijard et al., 1995).”
BackgroundInfluentialLee, J., Shin, J., Park, J. Y., Kwon, D., Choi, S. ‐., Kim, S. ‐., & Choi, I. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10815 · Cited by 33
“MKK6, the major form for p38 kinase phosphorylation (Derijard et al., 1995), is highly expressed in many tissues, but it was absent in brain tissues (Han et al.”
BackgroundSignaling Via the Interferon-α Receptor in Chronic Myelogenous Leukemia Cells
Verma, A., & Platanias, L. C. (2002) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190290016782 · Cited by 33
“MKK3 and MKK6 exhibit specificity for p38 [77], while MKK4 is also an activator of JNK [72,73].”
BackgroundThe citrus flavonoid, nobiletin inhibits neuronal inflammation by preventing the activation of NF-κB
Murata, T., Ishiwa, S., Lin, X., Nakazawa, Y., Tago, K., & Funakoshi‐Tago, M. (2023) · Neurochemistry International · doi:10.1016/j.neuint.2023.105613 · Cited by 32
Trafficking of Kainate Receptors
Pahl, S., Tapken, D., Haering, S., & Hollmann, M. (2014) · Membranes · doi:10.3390/membranes4030565 · Cited by 31
“This results in activation of JNK kinases [107,108] and an NMDA receptor-independent form of glutamate-mediated excitotoxicity [109–112], and is linked to neuronal loss upon ischemic injury [112–114].”
BackgroundFrancis, D. M., Kumar, G. S., Koveal, D., Tortajada, A., Page, R., & Peti, W. (2013) · Structure · doi:10.1016/j.str.2013.07.003 · Cited by 21
Rempel-Clower, N. L., & Barbas, H. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980831)398:3
Metadata
- Authors
- Dérijard, B., Raingeaud, J., Barrett, T., Wu, I.-H., Han, J., Ulevitch, R. J., & Davis, R. J.
- Affiliations
- University of Massachusetts Chan Medical School (US)
- Venue
- Science
- Published
- 1995-02-03
- Volume
- 267
- Issue
- 5198
- Pages
- 682-685
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1998487776
- Cited by
- 1,555
- References
- 29
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 9 · 2023: 12 · 2022: 16 · 2021: 19 · 2020: 14 · 2019: 20 · 2018: 16 · 2017: 19 · 2016: 24 · 2015: 15 · 2014: 27 · 2013: 25 · 2012: 27
- FWCI
- 53.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ca058396-09)
- National Cancer Institute (CA 58396)
- National Institute of General Medical Sciences (GM 37696, P01GM037696)
- National Institute of Allergy and Infectious Diseases (AI 15136, R01AI015136)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- MAPK signaling, MKK3, MKK4, p38 MAPK, ERK, JNK, signaling pathways, dual phosphorylation
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Cell Line, Cloning, Molecular, Enzyme Activation, Humans, Molecular Sequence Data, Phosphorylation, Protein-Tyrosine Kinases, Substrate Specificity, Transfection, Signal Transduction, Protein Serine-Threonine Kinases, Calcium-Calmodulin-Dependent Protein Kinases, Mitogen-Activated Protein Kinase 1, Mitogen-Activated Protein Kinases, Mitogen-Activated Protein Kinase Kinases, JNK Mitogen-Activated Protein Kinases, p38 Mitogen-Activated Protein Kinases, MAP Kinase Kinase 3, MAP Kinase Kinase 4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review